Endometrial Cancer in the United States: A Review of the Current Literature
DOI:
https://doi.org/10.17140/WHOJ-6-138Keywords:
Endometrial cancer; the United States; ReviewAbstract
Endometrial cancer is cancer of, or from, the endometrium of the uterus. According to the ACS, it is estimated that, in the United States, about 61,880 cases of cancers of the body of the uterus will be diagnosed in 2019 alone, while about 12,160 women
will die from the disease. There are several types and classifications of endometrial cancer based on basic histological or clinical
features, or a combination of both. Most of the current interventions have been focused on early detection especially in high-risk
women. This is a review of the epidemiology and risk factors, public health actions, and latest interventions in the management
of endometrial cancer in the United States.
References
Centers for Disease Control and Prevention (CDC). Basic In-formation About Uterine Cancer. cdc Web site. https://www.cdc. gov/cancer/uterine/basic_info/index.htm. Accessed July 5, 2020.
Arya LA, Schwartz N. Female reproductive system. In: Stan-dring S, ed. Gray’s Anatomy. Philadelphia, PA, USA: Elsevier Limit-ed. 2015: 1288-1313.e1.
International Federation of Gynecology and Obstetrics (FIGO). Cancer of the corpus uteri. figo.org Web site. https://www.figo. org/news/cancer-corpus-uteri-0016166. Accessed July 5, 2020.
American Cancer Society (ACS). Key Statistics for Endometrial Cancer. cancer.org Web site. https://www.cancer.org/cancer/en-dometrial-cancer/about/key-statistics.html. Accessed July 5, 2020.
Mariotto AB, Yabroff KR, Shao Y, Feuer EJ. Brown ML. Projec-tions of the cost of cancer care in the U.S.: 2010-2020. J Natl Cancer Inst. 2011; 103(2): 117-128. doi: 10.1093/jnci/djq495
American Cancer Society. What is endometrial cancer? cancer Web site. https://www.cancer.org/cancer/endometrial-cancer/ about/what-is-endometrial-cancer.html. Accessed July 5, 2020.
Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the Mini Review | Volume 6 | Number 1 | Fasehun OO et al corpus uteri. Int J Gynecol Obstet. 2018; 143 (Suppl. 2): 37-50. doi: 10.1002/ijgo.12612
Centers for Disease Control and Prevention (CDC). United States Cancer Statistics: Data Visualizations Tool. gis.cdc.gov Web site. https://www.cdc.gov/cancer/dcpc/data/index.htm. Ac-cessed July 5, 2020.
National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Uterine Cancer. seer.cancer Web site. https://seer.cancer.gov/statfacts/html/corp.html. Ac-cessed July 5, 2020.
Doll KM, Snyder CR, Ford CL. Endometrial cancer dispari-ties: a race-conscious critique of the literature. Am J Obstet Gynecol. 2018; 218(5): 474-482.e2. doi: 10.1016/j.ajog.2017.09.016
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body- mass index and incidence of cancer: A systematic review and meta- analysis of prospective observational studies. Lancet. 2008; 371: 569-578.
American Cancer Society (ACS). Endometrial Cancer Risk Fac-tors. cancer Web site. https://www.cancer.org/cancer/endometri-al-cancer/causes-risks-prevention/risk-factors.html. Accessed July 5, 2020.
Tafe LJ, Riggs ER, Tsongalis GJ. Lynch syndrome presenting as endometrial cancer. Clinical Chemistry. 2014; 60(1): 111-121. doi: 10.1373/clinchem.2013.206888
GovTrack. H.R. 1245 (109th) Congress: Gynecologic Cancer Education and Awareness Act of 2005. Web site. https://www. govtrack.us/congress/bills/109/hr1245. Accessed July 5, 2020.
Centers for Disease Control and Prevention (CDC). About the Inside Knowledge Campaign. cdc.gov Web site. https://www.cdc. gov/cancer/gynecologic/knowledge/about.htm. Accessed July 5, 2020.
Makker V, Rasco D, Vogelzang NJ, Brose MS, Cohn AL, Mier J, et al. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: An interim analysis of a multicentre, open-la-bel, single-arm, phase 2 trial. Lancet Oncolo. 2019; 20 (5), 711-718.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Women's Health (WH) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
